CSIMarket Company Name, Ticker, Suppliers, else..


Nkgen Biotech Inc   (NKGN)
Other Ticker:  
 

Nkgen Biotech Inc

NKGN's Fundamental analysis



Looking into Nkgen Biotech Inc growth rates, revenue grew in the fourth quarter of 2024 from the same quarter a year ago.

Biotechnology & Pharmaceuticals industry recorded deterioration of revenues by -2.05 %

Nkgen Biotech Inc realized net income compared to net loss a year ago in fourth quarter of 2024

• More on NKGN's Growth


Nkgen Biotech Inc
realized a net loss in trailing twelve months.

Nkgen Biotech Inc realized cash reduction of $ -0 per share in trailing twelve-month period.
Biotechnology & Pharmaceuticals industry recorded net loss in trailing twelve months.
Company
-
PE TTM   
Industry
-
PE TTM    
Company's Price to Sales ratio is at 0.05.
Biotechnology & Pharmaceuticals industry's Price to Sales ratio is at 7.04.


• More on NKGN's Valuation
 
 Total Debt (Millions $) 49
 Dividend TTM ($) 0 $
 Dividend Yield TTM (%) -
 Revenue/Employee (TTM) $ 258,429
 Net Income/Employee (TTM) $ -453,167
 Receivable Turnover (TTM) -
 Tangible Book Value (Per Share $) -2.43

Nkgen Biotech Inc
realized net loss in trailing twelve months.

Nkgen Biotech Inc realized cash outflow of $ -0per share in trailing twelve-month period.
Biotechnology & Pharmaceuticals industry recorded net loss in trailing twelve months.
Company
-
PE TTM   
Industry
-
PE TTM    
Company's Price to Sales ratio is at 0.05.
Biotechnology & Pharmaceuticals industry's Price to Sales ratio is at 7.04.


• More on NKGN's Valuation

•  Market Capitalization (Millions $) 1
•  Shares Outstanding (Millions) 29
•  Employees 42
•  Revenues (TTM) (Millions $) 11
•  Net Income (TTM) (Millions $) -19
•  Cash Flow (TTM) (Millions $) 0
•  Capital Exp. (TTM) (Millions $) 0
•  Total Debt (Millions $) 49
•  Dividend TTM ($) 0 $
•  Dividend Yield TTM (%) -
•  Revenue/Employee (TTM) $ 258,429
•  Net Income/Employee(TTM) $ -453,167
•  Receivable Turnover Ratio (TTM) -
•  Tangible Book Value (Per Share $) -2.43

•  Market Capitalization (Millions $) 1
•  Shares Outstanding (Millions) 29
•  Employees 42
•  Revenues (TTM) (Millions $) 11
•  Net Income (TTM) (Millions $) -19
•  Cash Flow (TTM) (Millions $) 0
•  Capital Exp. (TTM) (Millions $) 0





  Ratio
•   Capital Ratio (MRQ) 0.04
•  Total Debt to Equity (MRQ) -
•  Tangible Leverage Ratio (MRQ) -
•  Asset Turnover Ratio (TTM) 0.69
•  Inventory Turnover Ratio (TTM) -





Nkgen Biotech Inc net profit margin of 49.73 % is currently ranking no. 8 in Biotechnology & Pharmaceuticals industry, ranking no. 36 in Healthcare sector and number 214 in S&P 500.

• More on NKGN's Key Ratios





Help

About us

Terms of Use

CSIMarket Company, Sector, Industry, Market Analysis, Stock Quotes, Earnings, Economy, News and Research.

Intraday data delayed per exchange requirements. All quotes are in local exchange time. Intraday data delayed 15 minutes for Nasdaq, and other exchanges. Fundamental and financial data for Stocks, Sector, Industry, and Economic Indicators provided by CSIMarket.com

Disclaimer: Information provided by CSIMarket.com is for informational purposes only and does not constitute investment advice, recommendation, or solicitation to buy or sell any security.

© 2025 CSIMarket.com — Proprietary financial dataset. All rights reserved. Redistribution or automated extraction prohibited.